Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 171 - 180 of 193 Results.

State Legislators Must Join Supreme Court in Protecting Wine Consumers
Douglas Glen Whitman | Commentary | May 27, 2005
Bringing the Consumer Revolution to the FDA
Alexander T. Tabarrok | Commentary | Apr. 25, 2005
An Opportunity Or a Threat: How to Have Safer, Less Expensive Drugs
Paul H. Rubin | Commentary | Dec. 7, 2004
Vaccine Shortage Leads To The FDA’s Doorstep
Arthur E. Foulkes, Nicolas Heidorn | Commentary | Oct. 22, 2004
Only Distributors Reap Harvest of Wine Shipping Ban
Douglas Glen Whitman | Commentary | July 9, 2004
Bush’s Prescription Pill Police State
Anthony Gregory | Commentary | Mar. 24, 2004
Will Reimportation Lower Prescription Drug Prices?
Ariel Dillon | Commentary | Aug. 20, 2003
Off-Label Drug Awareness Saves Lives
Alexander T. Tabarrok, Daniel B. Klein | Commentary | Feb. 25, 2003
The FDA Needs a Big Dose of Economics
Daniel B. Klein, Alexander T. Tabarrok | Commentary | Oct. 25, 2002
Two Bright Ideas to Reduce Drug Prices
Alexander T. Tabarrok | Commentary | June 24, 2002






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL